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Abstract
Background: DNA methylation profiling of pediatric brain tumors offers a new way of diagnosing and subgrouping
these tumors which improves current clinical diagnostics based on histopathology. We have therefore developed the
MethPed classifier, which is a multiclass random forest algorithm, based on DNA methylation profiles from many
subgroups of pediatric brain tumors.
Results: We developed an R package that implements the MethPed classifier, making it easily available and accessible.
The package can be used for estimating the probability that an unknown sample belongs to each of nine pediatric
brain tumor diagnoses/subgroups.
Conclusions: The MethPed R package efficiently classifies pediatric brain tumors using the developed MethPed
classifier. MethPed is available via Bioconductor: http://bioconductor.org/packages/MethPed/
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Background
Carcinogenesis involves changes in gene expression that
results in tumor specific gene and protein signatures.
Such signatures have been used to classify different
subtypes of cancers. Gene expression is partly regulated
by the methylation state of CpG islands. Cancer tissue is
characterized by an increased variability in DNA methy-
lation patterns. DNA methylation profiling has been
reported as a robust method to classify and subgroup
tumors of different origin [1]. For most pediatric brain
tumor diagnoses, methylation profiling can divide the
tumors into clinically relevant subgroups reflecting the
diverse biology of the different subtypes which further
highlights the need for specific therapeutic strategies to
target different subgroups. With the increased knowledge
about specific brain tumor subgroups and the development
of targeted therapy for different entities, it is essential to
quickly and accurately determine the correct diagnosis for
pediatric brain tumor patients. The most popular and
commonly used platform for genome-wide methylation
profiling is the Illumina Infinium Human Methylation
450 BeadChip arrays. These arrays profile ~485,000
CpG sites and have been used by the Cancer Genome
Atlas Project (TCGA) and in numerous studies of
pediatric brain tumors. A correct diagnosis is vital for
determining the appropriate treatment protocol for a
specific patient, to select the right patients for clinical
trials investigating novel therapy for specific diagnoses
and subgroups and for basic researchers to be able to
draw correct conclusions from experiments. We therefore
developed the MethPed classifier [2], which is a multiclass
random forest algorithm [3], based on DNA methylation
profiles from many subgroups of pediatric brain tumors.
We have now developed an R package that uses this
method, making it easily available and accessible.
Implementation
The MethPed classifier was developed using the Random
Forest (RF) algorithm [3] for robust classification of
unknown brain tumor samples into subtypes as described
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in Danielsson et al. [2]. Briefly, the RF algorithm was
applied on beta values which are the estimate of methyla-
tion levels (between 0 and 1 with 0 being unmethylated
and 1 fully methylated) using the ratio of intensities
between methylated and unmethylated alleles gener-
ated by the Illumina Infinium HumanMethylation 450
BeadChip array. A training probe pool of 900 methylation
sites that showed the highest predictive power (AUC
values) in a large number of regression analyses was
selected from 472 clinically diagnosed brain tumor cases
available on GEO after necessary data cleaning and KNN
imputation of missing values. The RF algorithm was then
applied to classify unknown samples based on the selected
training probe pool. See Fig. 1 for a summary of the work-
flow for the MethPed classifier and R package.
The MethPed classifier can be accessed through the
‘MethPed’ package that can be downloaded from Bio-
conductor, a repository for bioinformatics related appli-
cations. The ‘MethPed’ package includes the MethPed
classifier and an example data set of two tumors. The
example data can be read into the R computing environ-
ment with the help of the data function after installing
the package.
Data for running MethPed is generated by the Illumina
Infinium HumanMethylation 450 BeadChip arrays. Beta
values for two samples (Tumor A and Tumor B) are pro-
vided with the ‘MethPed’ package as an example [2]. This
data has no missing values. If missing values exist in a
data set, the impute package can be used for missing
value imputation, according to the MethPed vignette in
Bioconductor.
Results and discussion
The MethPed analysis starts with loading the data, checking
for missing values in the data file and thereafter runs
through the classification. Error rate of the prediction is
estimated and the probability that a sample belongs to one
of nine tumor diagnoses/subgroups is given. In the current
version of MethPed the following groups are included; glio-
blastoma (GBM), pilocytic astrocytoma, medulloblastoma
(Wnt, Shh, group 3 and group 4), diffuse intrinsic pontine
glioma (DIPG), ependymoma and embryonal tumor with
multilayered rosettes (ETMR). These include the most
common diagnoses and subgroups but not all. The robust-
ness of a classifier is highly dependent on the accuracy of
the training data and therefore we choose not to build in
groups with limited data avaliable. With the MethPed
classifier, the probability that a tumor sample belongs to a
specific tumor group is presented (Fig. 2a), or if preferred,
the group with the maximum probability leaving zero to
the other tumor groups by supplying an extra parameter
‘prob = FALSE’ in the classifier (Fig. 2b). It should be note
that for tumors belonging to diagnoses that are not
included in the MethPed classification, these will be
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Fig. 1 Implementation and workflow of the MethPed classifier and package
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classified as inconclusive (with low probabilities of
belonging to any of the groups) or to the most similar
tumor form that is present in the classifier. For more
information, see Danielsson et al. [2].
The conditional probability matrix of the classification
from the MethPed output can be observed by the ‘sum-
mary’ command in R. For visualization of the prediction,
bar plots can be generated by using the ‘plot’ command
(Fig. 2). If missing probes from the sample compared
with the training data included with the package exist,
these can be observed by the ‘probeMis’ command.
MethPed is currently the only publically available tool
for classification of pediatric brain tumors. The use of
methylation profiling for classification of these tumors adds
new and important knowledge in the clinical setting for
choosing the optimal care and treatment of these patients
and will therefore likely complement histopathological
diagnoses in the near future [1, 2].
Conclusions
The MethPed R package can be used to efficiently classify
pediatric brain tumors using DNA methylation profiles
generated by the Illumina 450 K methylation arrays.
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Fig. 2 Bar plots on the diagnosis prediction of the two test samples. a Classification probability of a sample belonging to each of the pediatric
brain tumor diagnoses currently included in MethPed and (b) Maximum classification probability of a specific tumor group for each sample
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